Russell Investments Group
ARTV icon

Russell Investments Group’s Artiva Biotherapeutics ARTV Stock Holding History

Russell Investments Group’s Portfolio ARTV Stock Details ARTV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$56.9K Buy
5,861
+370
+7% +$3.37K ﹤0.01% 3591
2026
Q1 		$35.4K Hold
5,491
– – ﹤0.01% 3440
2025
Q4 		$23.6K Hold
5,491
– – ﹤0.01% 3571
2025
Q3 		$15.8K Hold
5,491
– – ﹤0.01% 3663
2025
Q2 		$8.29K Buy
+5,491
New +$11.5K ﹤0.01% 3367

Other funds holding ARTV

RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $39B AUM 18.55% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return

Russell Investments Group's ARTV Position: Q2 2026 in Review

Russell Investments Group increased its Artiva Biotherapeutics (ARTV) stake by 6.7% in Q2 2026, buying an estimated $3.37K and bringing the position to 5,861 shares worth $56.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3591.

Russell Investments Group first reported a position in ARTV in Q2 2025 and has held it in 5 quarters since. 72 funds tracked by Wall St. Rank hold ARTV as of Q2 2026.

  • Russell Investments Group held 5,861 shares of Artiva Biotherapeutics worth $56.9K as of Q2 2026.
  • Russell Investments Group bought 370 Artiva Biotherapeutics shares in Q2 2026, an estimated $3.37K.
  • Artiva Biotherapeutics made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3591 holding.
  • Russell Investments Group first reported a position in Artiva Biotherapeutics in Q2 2025 and has held it in 5 quarters since.
  • 72 funds tracked by Wall St. Rank held Artiva Biotherapeutics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.